Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis

INTRODUCTION: Tumor necrosis factor inhibitors (TNFis) may be administered at a reduced dose to patients with ankylosing spondylitis (AS) for various reasons. However, in practice, there is insufficient evidence of how the dose reduction of TNFi is implemented and the amount of medical costs it redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Bon San, Lim, Yu-Cheol, Lee, Min-Young, Jeon, Ja-Young, Yoo, Hyun-Jeong, Oh, In-Sun, Shin, Ju-Young, Kim, Tae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991020/
https://www.ncbi.nlm.nih.gov/pubmed/33420967
http://dx.doi.org/10.1007/s40744-020-00274-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991020/
https://www.ncbi.nlm.nih.gov/pubmed/33420967
http://dx.doi.org/10.1007/s40744-020-00274-9

Ejemplares similares